Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 78.0
(0.22%)
INR 78.0
(0.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 38.94 Million INR | -20.85% |
| 2022 | 30.87 Million INR | -8.54% |
| 2021 | 33.75 Million INR | 10.84% |
| 2020 | 30.45 Million INR | 11.17% |
| 2019 | 27.39 Million INR | 31.47% |
| 2018 | 20.83 Million INR | 24.72% |
| 2017 | 16.7 Million INR | 8.19% |
| 2016 | 15.44 Million INR | 22.3% |
| 2015 | 12.62 Million INR | -12.4% |
| 2014 | 14.41 Million INR | -9.29% |
| 2013 | 15.89 Million INR | -5.17% |
| 2012 | 16.75 Million INR | 7.86% |
| 2011 | 15.53 Million INR | -41.0% |
| 2010 | 26.33 Million INR | 45.18% |
| 2009 | 18.13 Million INR | 2.66% |
| 2008 | 17.66 Million INR | 5.65% |
| 2007 | 16.72 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5.8 Million INR | -7.6% |
| 2023 Q4 | 6.27 Million INR | 33.78% |
| 2023 Q1 | 9.7 Million INR | 119.6% |
| 2023 Q2 | 10.99 Million INR | 13.37% |
| 2023 FY | 24.43 Million INR | -20.85% |
| 2023 Q3 | 4.69 Million INR | -57.34% |
| 2022 Q2 | 7.68 Million INR | -19.2% |
| 2022 Q3 | 9.25 Million INR | 20.33% |
| 2022 Q4 | 4.41 Million INR | -52.24% |
| 2022 FY | 30.87 Million INR | -8.54% |
| 2022 Q1 | 9.51 Million INR | 29.74% |
| 2021 Q4 | 7.33 Million INR | -11.84% |
| 2021 Q1 | 9.3 Million INR | 60.52% |
| 2021 Q2 | 8.8 Million INR | -5.41% |
| 2021 Q3 | 8.31 Million INR | -5.47% |
| 2021 FY | 33.75 Million INR | 10.84% |
| 2020 Q3 | 8.37 Million INR | -1.73% |
| 2020 FY | 30.45 Million INR | 11.17% |
| 2020 Q4 | 5.79 Million INR | -30.8% |
| 2020 Q2 | 8.52 Million INR | 9.81% |
| 2020 Q1 | 7.76 Million INR | 94.55% |
| 2019 FY | 27.39 Million INR | 31.47% |
| 2019 Q4 | 3.98 Million INR | -45.93% |
| 2019 Q3 | 7.37 Million INR | -8.63% |
| 2019 Q2 | 8.07 Million INR | 1.53% |
| 2019 Q1 | 7.95 Million INR | 1180.75% |
| 2018 Q2 | 6.6 Million INR | 5.16% |
| 2018 Q4 | 620.96 Thousand INR | -91.53% |
| 2018 FY | 20.83 Million INR | 24.72% |
| 2018 Q1 | 6.28 Million INR | 18.24% |
| 2018 Q3 | 7.33 Million INR | 11.02% |
| 2017 Q2 | 4.72 Million INR | -32.29% |
| 2017 Q1 | 6.97 Million INR | -4.2% |
| 2017 FY | 16.7 Million INR | 8.19% |
| 2017 Q4 | 5.31 Million INR | 15.35% |
| 2017 Q3 | 4.6 Million INR | -2.52% |
| 2016 Q1 | 5.11 Million INR | -11.21% |
| 2016 FY | 15.44 Million INR | 22.3% |
| 2016 Q2 | 5.13 Million INR | 0.35% |
| 2016 Q4 | 7.28 Million INR | 7.9% |
| 2016 Q3 | 6.75 Million INR | 31.5% |
| 2015 FY | 12.62 Million INR | -12.4% |
| 2015 Q4 | 5.76 Million INR | 14.6% |
| 2015 Q3 | 5.02 Million INR | 30.11% |
| 2015 Q1 | 6.08 Million INR | 294.54% |
| 2015 Q2 | 3.86 Million INR | -36.52% |
| 2014 Q2 | 6.4 Million INR | 17.47% |
| 2014 Q1 | 5.44 Million INR | 293.21% |
| 2014 FY | 14.41 Million INR | -9.29% |
| 2014 Q4 | -3.12 Million INR | -142.84% |
| 2014 Q3 | 7.3 Million INR | 14.08% |
| 2013 Q3 | 6.28 Million INR | 2.48% |
| 2013 Q2 | 6.13 Million INR | -3.02% |
| 2013 Q4 | -2.82 Million INR | -144.87% |
| 2013 Q1 | 6.32 Million INR | -27.69% |
| 2013 FY | 15.89 Million INR | -5.17% |
| 2012 Q1 | 5 Million INR | 34.79% |
| 2012 Q4 | 8.74 Million INR | 3.49% |
| 2012 FY | 16.75 Million INR | 7.86% |
| 2012 Q3 | 8.45 Million INR | 4.72% |
| 2012 Q2 | 8.07 Million INR | 61.23% |
| 2011 FY | 15.53 Million INR | -41.0% |
| 2011 Q4 | 3.71 Million INR | -7.1% |
| 2011 Q3 | 3.99 Million INR | 0.0% |
| 2010 Q4 | 9.81 Million INR | 0.0% |
| 2010 FY | 26.33 Million INR | 45.18% |
| 2009 Q4 | 4.6 Million INR | 0.0% |
| 2009 FY | 18.13 Million INR | 2.66% |
| 2008 Q4 | 4.69 Million INR | 0.0% |
| 2008 FY | 17.66 Million INR | 5.65% |
| 2007 FY | 16.72 Million INR | 0.0% |
| 2007 Q4 | 4.38 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Beryl Drugs Limited | 108.5 Million INR | 64.111% |
| ANG Lifesciences India Limited | 232.73 Million INR | 83.268% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 82.623% |
| Bacil Pharma Limited | -19.95 Thousand INR | 195292.982% |
| BDH Industries Limited | 175.55 Million INR | 77.818% |
| Cian Healthcare Limited | 113.16 Million INR | 65.59% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -111.843% |
| Colinz Laboratories Limited | 16.35 Million INR | -138.098% |
| Mercury Laboratories Limited | 279.39 Million INR | 86.062% |
| Concord Drugs Limited | 116.7 Million INR | 66.633% |
| Deccan Health Care Limited | 221.57 Million INR | 82.425% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 88.247% |
| Phaarmasia Limited | 38.89 Million INR | -0.131% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 72.462% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 96.963% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -1140.064% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 96.486% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 65.158% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 97.29% |
| Makers Laboratories Limited | 308.54 Million INR | 87.379% |
| Medi-Caps Limited | 68.09 Million INR | 42.811% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.684% |
| Parmax Pharma Limited | 99.31 Million INR | 60.791% |
| Parnax Lab Limited | 552.1 Million INR | 92.947% |
| Patidar Buildcon Limited | -26 Thousand INR | 149873.077% |
| PRAVEG LIMITED | 266.99 Million INR | 85.415% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 96.754% |
| Smruthi Organics Limited | 324.76 Million INR | 88.009% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 89.236% |
| Sunil Healthcare Limited | 247.86 Million INR | 84.289% |
| Syschem (India) Limited | 569.04 Million INR | 93.157% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 81.357% |
| Transchem Limited | -8.96 Million INR | 534.318% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 9691.379% |
| Trinity League India Limited | 1.23 Million INR | -3060.795% |
| Tyche Industries Limited | 290.84 Million INR | 86.611% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 41.009% |
| Trident Lifeline Limited | 119.08 Million INR | 67.299% |
| Denis Chem Lab Limited | 596.24 Million INR | 93.469% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -288.633% |
| Panchsheel Organics Limited | 356.44 Million INR | 89.075% |
| Zenith Healthcare Limited | 46.17 Million INR | 15.665% |
| Zenlabs Ethica Limited | 147.75 Million INR | 73.645% |
| Vivanza Biosciences Limited | 19.38 Million INR | -100.861% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 91.224% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 64.909% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 81.25% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 126.549% |
| Roopa Industries Limited | 72.95 Million INR | 46.622% |
| PANJON LTD. | 33.77 Million INR | -15.282% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 153.477% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 318.647% |
| Anuh Pharma Limited | 1.6 Billion INR | 97.571% |
| Crestchem Limited | 51.53 Million INR | 24.442% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 623.893% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 88.781% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 94.627% |
| Trimurthi Limited | 1.95 Million INR | -1895.951% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 87.036% |
| Norris Medicines Limited | 29.36 Million INR | -32.622% |
| Veerhealth Care Limited | 49.57 Million INR | 21.449% |
| Lactose (India) Limited | 230.3 Million INR | 83.092% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 139.022% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 94.574% |
| Gennex Laboratories Limited | 276.99 Million INR | 85.942% |
| Godavari Drugs Limited | 359.01 Million INR | 89.153% |
| Zenotech Laboratories Limited | 337.19 Million INR | 88.452% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 94.224% |
| Bharat Parenterals Limited | 989.46 Million INR | 96.064% |
| Coral Laboratories Limited | 332.39 Million INR | 88.285% |
| Evoq Remedies Limited | 47.43 Million INR | 17.905% |
| Kerala Ayurveda Limited | 447.69 Million INR | 91.302% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 195.645% |
| Natural Capsules Limited | 557.1 Million INR | 93.01% |
| Auro Laboratories Limited | 249.39 Million INR | 84.386% |